In earnings calls, diabetes tech companies had less to say about tariffs and focused more on future growth.

An AI tool showed noninferiority to senior endocrinology physicians in insulin titration for hospitalized patients with type ...

On the other hand, a striking moment was experienced at the Madrid Open when the 'soldiers' from Squid Game entered the stands in a fun contest for the fans. Additionally, Alexandra Eala joked about ...

In this article, we are going to take a look at where DexCom, Inc. (NASDAQ:DXCM) stands against other Friday’s top performers. The stock market ended the trading week on a strong note ...

DexCom Inc designs, develops and commercializes continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers in the hospital for the treatment ...

Short interest in DexCom Inc (NASDAQ:DXCM) decreased during the last reporting period, falling from 11.01M to 10.61M. This put 3.47% of the company's publicly available shares short. Short ...

DexCom Inc shares are currently trading up about 15.7% on the day. The chart below shows the one year performance of DXCM shares, versus its 200 day moving average: ...

DexCom, Inc. DXCM reported first-quarter 2025 adjusted earnings per share (EPS) of 32 cents, which missed the Zacks Consensus Estimate of 33 cents by 3%. The company also reported earnings of 32 ...

Kevin Sayer; Chairman of the Board, President, Chief Executive Officer; Dexcom Inc Jereme Sylvain; Chief Financial Officer, Executive Vice President; Dexcom Inc Jake Leach; Executive Vice President, ...

Keep in mind that side effects of a drug can depend on: your age other health conditions you have other medications you take your dosage Your doctor or pharmacist can tell you more about the ...

For example, in the figure below taken from an FX chart, the bearish engulfing line’s body does not exactly engulf the previous day’s body, but the upper wick does. With a little imagination ...

Rinvoq approved for giant cell arteritis; telehealth companies collaborate with Novo Nordisk for Wegovy access; epidermolysis bullosa wound healing treatment approved; Imaavy approved for gMG; new ...